Mechanism of inhibitor action

Kinase Inhibitors Mechanism of Action Biological Consequences... 

Cushman, D. W., Cheung, H. S., Sabo, E. F., and Ondetti, M. A. (1981). Angiotensinconverting enzyme inhibitors Evaluation of a new class of antihypertensive drugs. In "Angiotensin-Converting Enzyme Inhibitors Mechanism of Action and Clinical Implications", (Z. P. Horovitz, Ed.), pp. 1-25. Urban and Schwarzenberg, Baltimore and Munich. 

TIs also inhibit the reverse transcriptase enzyme s ability to perform one of the initial steps in HIV replication. The NNRTIs, however, directly inhibit the active (catalytic) site on this enzyme, whereas zidovudine and other NRTIs serve as false substrates that take the place of the substance (thymidine) normally acted on by this enzyme (see Reverse Transcriptase Inhibitors Mechanism of Action ). Hence, NNRTIs provide another way to impair one of the key steps in HIV replication, and these drugs can be used along with other agents (NRTIs, protease inhibitors) to provide optimal benefits in preventing HIV replication and proliferation (see the next section). 

Bajgar, J. (1985). Intoxication with organophosphoras cholinesterase inhibitors. Mechanism of action, diagnosis and treatment. In Novinky v medicine News in Medicine), Vol. 34, pp. 7-40. Avicenum, Prague. (In Czech)... 

The expression levels of proteins in HeLa cells treated with 19 well-known inhibitors were successfully classified by cluster analysis according to the inhibitors mechanisms of action. Thus, we have since constructed a database from which expression data from separate experiments can be compared. Proteomic analyses of HeLa cells are performed after 18 h of exposure to test compounds at a concentration that inhibits cell growth by 80% or more. The expression data obtained from the around 300 spots, reproducibly detected in 2D-electrophoresis images of HeLa cell lysates, were used to calculate the ratio of each spot in treated and control cells and compare these ratios to the dataset in ChemProteoBase. 

Bartolini, M. Bertucci, C. Bolognesi, M. L. Cavalli, A. Melchiorre, C. Andrisano, V. Insight into the kinetic of amyloid P (1-42) peptide self-aggregation elucidation of inhibitors mechanism of action. ChemBioChem 2007, 8, 2152-2161. 

Selected for clinical trials as a compound to calm agitated patients, imipramine was relatively ineffective. However, it was observed to be effective in the treatment of certain depressed patients (38). Early studies on the mechanism of action showed that imipramine potentiates the effects of the catecholamines, primarily norepinephrine. This finding, along with other evidence, led to the hypothesis that the compound exerts its antidepressant effects by elevating norepinephrine levels at central adrenergic synapses. Subsequent studies have shown that the compound is a potent inhibitor of norepinephrine reuptake and, to a lesser extent, the uptake of serotonin, thus fitting the hypothesis that had been developed to explain the antidepressant actions ofMAOIs. 

The sulfated compounds MM 13902 (3, n = (5) and MM 17880 (4) are also broad-spectmm agents, but not as potent as thienamycia and all lack any significant activity against Pseudomonas (73). Many carbapenems are excellent inhibitors of isolated P-lactamases, particularly the olivanic acid sulfoxide MM 4550 (3, n = 1) (3). The possible mechanism of action of the carbapenems as inhibitors of P-lactamases has been discussed in some detail (74). Other carbapenems such as PS-5 (5) (75), the carpetimycins (76), asparenomycins (77), and pluracidomycins (8) are all highly active as antibiotics or P-lactamase inhibitors. The parent nucleus itself (1, X = CH2) is intrinsically active, but chemically unstable (9). 

Clavulanic acid has only weak antibacterial activity, but is a potent irreversible inhibitor for many clinically important P-lactamases (10—14,57,58) including penases, and Richmond-Sykes types 11, 111, IV, V, VI ([Bacteroides). Type I Cephases are poorly inhibited. Clavulanic acid synergizes the activity of many penicillins and cephalosporins against resistant strains. The chemistry (59—63), microbiology (64,65), stmcture activity relationships (10,13,60—62,66), biosynthesis (67—69), and mechanism of action (6,26,27,67) have been reviewed. 

Chelation is a feature of much research on the development and mechanism of action of catalysts. For example, enzyme chemistry is aided by the study of reactions of simpler chelates that are models of enzyme reactions. Certain enzymes, coenzymes, and vitamins possess chelate stmctures that must be involved in the mechanism of their action. The activation of many enzymes by metal ions most likely involves chelation, probably bridging the enzyme and substrate through the metal atom. Enzyme inhibition may often result from the formation by the inhibitor of a chelate with a greater stabiUty constant than that of the substrate or the enzyme for a necessary metal ion. 

Atmospheric corrosion can be prevented by using volatile inhibitors which need not be applied directly to the surfaces to be protected. Most such inhibitors are amine nitrites, benzoates, chromates, etc. They are mainly used with ferrous metals. There is still some disagreement as to the mechanism of action. Clearly, any moisture that condenses must be converted to an inhibitive solution. There is no doubt that the widely used volatile inhibitors are effective in aqueous solutions containing moderate... 

The mechanisms of action of inhibitors which form salt films on metals have been reviewed. ... 

Watson, C., Jenkinson, S., Kazmierski,W., and Kenakin, T. P. (2005). The CCR5 receptor-based mechanism of action of 873140, a potent allosteric non-competitive HIV entry-inhibitor. Mol. Pharmacol. 67 1268—1282. 

HMG-CoA-Reductase Inhibitors. Figure 1 Mechanism of action of statins - cholesterol synthesis pathway. The conversion of acetyl CoA to cholesterol in the liver. The step of cholesterol biosynthesis inhibited by HMG-CoA reductase inhibitors (statins) is shown. 

There are several hundred reported NF-kB inhibitors (see www.nf-kb.org for a complete and updated list). These inhibitors include natural products, chemicals, metabolites, and synthetic compounds. A large majority of these products, in particular commonly used antiinflammatory drugs such as corticosteroids and the nonsteroidal antiinflammatory drugs (NSADDs) aspirin, sulindac, ibuprofen and sulphasalazine, have the ability to partially inhibit NF-kB activity in cell culture. However, the precise mechanism of action and the specific molecular targets of most of these inhibitors remain unclear. 

The introduction of PP2B (calcinemin) inhibitors revolutionized kidney transplantation. Cyclosporine A and tacrolimus (FK506) are the principal immunosuppressants prescribed for adult and pediatric renal transplantation. Cyclosporine A was in use clinically long before its mechanism of action was elucidated. 

Vasodilators are a group of dtugs, which relax the smooth muscle cells of the blood vessels and lead to an increased local tissue blood flow, a reduced arterial pressure and a reduced central venous pressure. Vasodilators reduce the cardiac pre-load as well as after-load and thereby reduce cardiac work. They are used in a variety of conditions including hypertension, cardiac failure and treatment/prevention of angina pectoris. Major groups are Ca2+-channel blockers (e.g. dihydropyridines), NO-donators (e.g. organic nitrates), K+-channel openers (minoxidil), phosphodiesterase inhibitors (e.g. sildenafil), Rho-kinase inhibitors (e.g. Y27632) or substances with unknown mechanism of action (e.g. hydralazine). Inhibitors of the... 

---